Atlas Trials

Triple Negative Breast Cancer (TNBC)

91 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Triple Negative Breast Cancer (TNBC)

RecordFirmDate
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (NCT04981119)A2 Biotherapeutics Inc.2021-10-29
A Study of NX-1607 in Adults With Advanced Malignancies (NCT05107674)Nurix Therapeutics, Inc.2021-09-29
Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (NCT05088057)Aiping Shi2021-09-20
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors (NCT04424641)Genmab2020-07-15
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (NCT03893955)AbbVie2019-05-21
A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC) (NCT03855358)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2019-05-09
Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC). (NCT03742349)Novartis Pharmaceuticals2019-01-31
A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431)Fusion Pharmaceuticals Inc.2019-01-17
QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine (NCT03554109)ImmunityBio, Inc.2018-09-01
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. (NCT03549000)Novartis Pharmaceuticals2018-07-18
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355) (NCT02819518)Merck Sharp & Dohme LLC2016-07-27
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) (NCT02698176)Merck Sharp & Dohme LLC2016-05-04
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers (NCT02178722)Incyte Corporation2014-07-17
AZD8186 First Time In Patient Ascending Dose Study (NCT01884285)AstraZeneca2013-07-09
Expanded Access to Veliparib (NCT03123211)AbbVie

Track Triple Negative Breast Cancer (TNBC) automatically

Every clearance here is in the API, with alerts when new ones post.